Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

LRMR - Larimar Therapeutics, Inc. Financial... | Finranks

Home

/

LRMR

L

Larimar Therapeutics, Inc. (LRMR)

NGM – Real Time Price. Currency in USD

4.32

+0.01 (0.23%)

Market open: Aug 12, 2026, 10:11 AM EDT

4.30

-0.01 (-0.23%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-350K

-318K

-311K

-272K

Gross Profit

-350K

-318K

-311K

-272K

Operating expenses (excl. COGS)

-172M

-91M

-41M

-36M

Operating Income

-172M

-91M

-42M

-37M

Non-operating income, total

7M

10M

5M

1M

Pretax income

-166M

-81M

-37M

-35M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-166M

-81M

-37M

-35M

Discontinued operations

0

0

0

0

Net income

-166M

-81M

-37M

-35M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

146M-27.1%

201M+109.4%

96M-24.1%

126M

Total current assets

142M

195M

90M

121M

Total non-current assets

4M

6M

6M

6M

Total liabilities

68M+134.8%

29M+104.9%

14M-8.3%

16M

Total current liabilities

65M

24M

10M

11M

Total non-current liabilities

4M

5M

5M

5M

Total equity

78M

172M

82M

111M

Total liabilities & shareholders' equities

146M

201M

96M

126M

Total debt

4M-20.5%

5M-7.7%

6M+2.6%

5M

Name

2025

2024

2023

2022

Cash from operating activities

-113M

-71M

-33M

-28M

Cash from investing activities

100M

-85M

33M

-91M

Cash from financing activities

65M

162M

30K

75M

Free cash flow

-113M-59.0%

-71M-112.0%

-34M-21.5%

-28M